Just a moment, the page is loading...

INNOVATE 2 #1 - Real-world use and impact on overall PrEP uptake and overall patient health in broad populations:


List of Countries eligible to participate: Brazil, Canada, France, Italy, Spain, United Kingdom and United States



Example research questions, but not limited to:
 
Does offering CAB LA for PrEP to broad populations result in:

   a) increased overall PrEP uptake, adherence and/or persistence
 
   b) a neutral or positive impact on tolerability (incl. metabolic, bone + renal markers) compared to oral PrEP options.


INNOVATE 2 RFP Submission Summary.pdf
INNOVATE 2 RFP Application Instructions.pdf
INNOVATE 2 RFP Concept Template.docx
- Back to Top -